NetraMark Holdings Inc. has appointed Dr. Panteli Theocharous as its Fractional Chief Medical Officer to enhance clinical leadership and accelerate the global adoption of its AI platform, NetraAI. Dr. Theocharous brings extensive expertise in clinical development and strategy, aiming to improve trial design and patient stratification using explainable AI. This move supports NetraMark's goal to increase trial success rates and efficiency by integrating advanced AI with clinical insights. The company also acknowledged outgoing CMO Dr. Larry Alphs, who will remain as an advisor during this transition.
Pepeto has completed a significant security upgrade on its DeFi exchange platform, drawing strong interest from XRP whale investors during its rapidly filling 2026 presale. This surge is linked to bullish XRP price forecasts and upcoming pro-crypto p...
IKIGAI Trading Academy, led by Qamar Zaman, has released Flight Path, a market-structure projection tool for SPX and SPY day traders. The tool helps traders plan trades by mapping bullish and bearish paths based on market structure before the open, e...
OpenAI's GPT-5.6 Sol model scored 88.8% on the TerminalBench 2.1 coding benchmark, significantly surpassing Anthropic's Claude Opus 4.8, which scored 78.9%. The Sol Ultra variant achieved an even higher score of 91.9% by using advanced techniques to ...
Bitcoin challenged the $63K level but failed to surpass it, bouncing from $58.5K earlier in July. Over $143 million in short liquidations indicate many traders were caught off-guard, suggesting a possible bullish reversal rather than just a short squ...
Google released a humorous commercial imagining the Founding Fathers using Google Workspace tools like Docs, Calendar, and Meet to draft the Declaration of Independence in 1776. The ad features AI tools such as Google's 'help me visualize' and Gemini...
